US watchdog flags top drugmakers for unsupported price hikes
ICER's value assessment framework
Understanding ICER's Evolving Influence on Drug Pricing and Negotiation
Drug Channels: A New JAMA Study Misleads About Drug Prices—And Launches a New Attack on Patients with Ultra-Rare Diseases
Build Back Better could set new precedent for US drug pricing controls-GPI
Elucidating ICER's methodologies for Unsupported Price Increase assessments
The Influence of US Drug Price Dynamics on Cost-Effectiveness Analyses of Biologics - Value in Health
5 angles to consider when covering drug-price reform - Association of Health Care Journalists
McKinsey taught Big Pharma how to price-gouge, by Cory Doctorow
JCM, Free Full-Text
Patients Don't Support Prescription Price Hikes (And Neither Does Clinical Evidence)
Prescription Drugs - CT Healthcare Explained
The Impact of Pharmaceutical Wholesalers on U.S. Drug Spending